TIAA Trust National Association Reduces Johnson & Johnson Stake

The investment firm lowered its position in the healthcare giant by 0.6% during the third quarter.

Feb. 27, 2026 at 2:34pm

TIAA Trust National Association, a major institutional investor, reduced its stake in Johnson & Johnson (NYSE:JNJ) by 0.6% during the third quarter of 2025. The firm now owns 340,134 shares of the company's stock, valued at $63,063,000 at the end of the reporting period.

Why it matters

As one of the largest healthcare companies in the world, changes in institutional ownership of Johnson & Johnson shares can provide insights into broader market sentiment and investor confidence in the firm's performance and future prospects.

The details

TIAA Trust National Association sold 2,102 shares of Johnson & Johnson stock during the third quarter, lowering its total position to 340,134 shares. The firm cited portfolio rebalancing and broader market conditions as factors behind the reduced stake in the healthcare giant.

  • TIAA Trust National Association reported the stake reduction in its 13F filing for the third quarter of 2025, which was published on February 27, 2026.

The players

TIAA Trust National Association

A major institutional investment firm that manages assets on behalf of teachers and other professionals.

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets a broad range of pharmaceutical, medical device, and consumer health products.

Got photos? Submit your photos here. ›

The takeaway

The reduction in TIAA Trust National Association's Johnson & Johnson stake, while relatively small, could signal broader market uncertainty or a shift in investment strategies among some institutional investors. However, Johnson & Johnson remains a major holding for many large funds, underscoring the company's continued importance in the healthcare sector.